New 3-Aminopropylsilatrane Derivatives: Synthesis, Structure, Properties, and Biological Activity. 2023

Sergey N Adamovich, and Igor A Ushakov, and Elizaveta N Oborina, and Svetlana V Lukyanova, and Vladislav Y Komarov
A.E. Favorsky Irkutsk Institute of Chemistry, Siberian Branch of the Russian Academy of Sciences, 1 Favorsky Street, 664033 Irkutsk, Russia.

The biologically active compound 3-aminopropylsilatrane (a compound with a pentacoordinated silicon atom) underwent an aza-Michael reaction with various acrylates and other Michael acceptors. Depending on the molar ratio, the reaction yielded Michael mono- or diadducts (11 examples) containing functional groups (silatranyl, carbonyl, nitrile, amino, etc.). These compounds were characterized via IR and NMR spectroscopy, mass spectrometry, X-ray diffraction, and elemental analysis. Calculations (using in silico, PASS, and SwissADMET online software) revealed that the functionalized (hybrid) silatranes were bioavailable, druglike compounds that exhibited pronounced antineoplastic and macrophage-colony-stimulating activity. The in vitro effect of silatranes on the growth of pathogenic bacteria (Listeria, Staphylococcus, and Yersinia) was studied. It was found that the synthesized compounds exerted inhibitory and stimulating effects in high and low concentrations, respectively.

UI MeSH Term Description Entries
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass
D014961 X-Ray Diffraction The scattering of x-rays by matter, especially crystals, with accompanying variation in intensity due to interference effects. Analysis of the crystal structure of materials is performed by passing x-rays through them and registering the diffraction image of the rays (CRYSTALLOGRAPHY, X-RAY). (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Xray Diffraction,Diffraction, X-Ray,Diffraction, Xray,Diffractions, X-Ray,Diffractions, Xray,X Ray Diffraction,X-Ray Diffractions,Xray Diffractions
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D017646 Organosilicon Compounds Organic compounds that contain silicon as an integral part of the molecule. Organosilane Compounds,Organosilanes

Related Publications

Sergey N Adamovich, and Igor A Ushakov, and Elizaveta N Oborina, and Svetlana V Lukyanova, and Vladislav Y Komarov
October 1993, Carbohydrate research,
Sergey N Adamovich, and Igor A Ushakov, and Elizaveta N Oborina, and Svetlana V Lukyanova, and Vladislav Y Komarov
July 2020, Acta crystallographica. Section C, Structural chemistry,
Sergey N Adamovich, and Igor A Ushakov, and Elizaveta N Oborina, and Svetlana V Lukyanova, and Vladislav Y Komarov
April 1993, Journal of medicinal chemistry,
Sergey N Adamovich, and Igor A Ushakov, and Elizaveta N Oborina, and Svetlana V Lukyanova, and Vladislav Y Komarov
July 2014, European journal of medicinal chemistry,
Sergey N Adamovich, and Igor A Ushakov, and Elizaveta N Oborina, and Svetlana V Lukyanova, and Vladislav Y Komarov
January 2014, Current topics in medicinal chemistry,
Sergey N Adamovich, and Igor A Ushakov, and Elizaveta N Oborina, and Svetlana V Lukyanova, and Vladislav Y Komarov
April 1998, Bioorganic & medicinal chemistry letters,
Sergey N Adamovich, and Igor A Ushakov, and Elizaveta N Oborina, and Svetlana V Lukyanova, and Vladislav Y Komarov
April 2009, Bioorganic & medicinal chemistry,
Sergey N Adamovich, and Igor A Ushakov, and Elizaveta N Oborina, and Svetlana V Lukyanova, and Vladislav Y Komarov
September 1990, The Journal of antibiotics,
Sergey N Adamovich, and Igor A Ushakov, and Elizaveta N Oborina, and Svetlana V Lukyanova, and Vladislav Y Komarov
May 2005, Bioorganic & medicinal chemistry,
Sergey N Adamovich, and Igor A Ushakov, and Elizaveta N Oborina, and Svetlana V Lukyanova, and Vladislav Y Komarov
March 1992, Journal of medicinal chemistry,
Copied contents to your clipboard!